Best Fit Profiles
- cognitive performance support stacks
Attention and memory support
Citicoline (CDP-Choline)
Human data suggest potential support for attention and selected cognitive tasks, with variability by population and protocol.
Evidence Level B
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Modest attention and memory-task support in selected groups
- Safety
- Low Risk
Can cause headaches or sleep disruption at higher doses in sensitive users.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 250-500 mg
- Timing
- Morning or early afternoon
- Protocol Duration in Studies
- 6-12 weeks in cognition studies
Earlier-day use is common to limit risk of sleep disturbance.